134 related articles for article (PubMed ID: 22185941)
1. Increased bioavailability of primaquine using poly(ethylene oxide) matrix extended-release tablets administered to beagle dogs.
Bertol CD; Oliveira PR; Kuminek G; Rauber GS; Stulzer HK; Silva MA
Ann Trop Med Parasitol; 2011 Oct; 105(7):475-84. PubMed ID: 22185941
[TBL] [Abstract][Full Text] [Related]
2. Galactose-Anchored Gelatin Nanoparticles for Primaquine Delivery and Improved Pharmacokinetics: A Biodegradable and Safe Approach for Effective Antiplasmodial Activity against P. falciparum 3D7 and in Vivo Hepatocyte Targeting.
Kumar H; Gothwal A; Khan I; Nakhate KT; Alexander A; Ajazuddin ; Singh V; Gupta U
Mol Pharm; 2017 Oct; 14(10):3356-3369. PubMed ID: 28836792
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics and pharmacodynamics of (+)-primaquine and (-)-primaquine enantiomers in rhesus macaques (Macaca mulatta).
Saunders D; Vanachayangkul P; Imerbsin R; Khemawoot P; Siripokasupkul R; Tekwani BL; Sampath A; Nanayakkara NP; Ohrt C; Lanteri C; Gettyacamin M; Teja-Isavadharm P; Walker L
Antimicrob Agents Chemother; 2014 Dec; 58(12):7283-91. PubMed ID: 25267666
[TBL] [Abstract][Full Text] [Related]
4. Monitoring the Efficacy of Chloroquine-Primaquine Therapy for Uncomplicated Plasmodium vivax Malaria in the Main Transmission Hot Spot of Brazil.
Ladeia-Andrade S; Menezes MJ; de Sousa TN; Silvino ACR; de Carvalho JF; Salla LC; Nery OA; de Melo GNP; Corder RM; Rodrigues PT; Ferreira MU
Antimicrob Agents Chemother; 2019 May; 63(5):. PubMed ID: 30782991
[TBL] [Abstract][Full Text] [Related]
5. Primaquine treatment and relapse in Plasmodium vivax malaria.
Rishikesh K; Saravu K
Pathog Glob Health; 2016; 110(1):1-8. PubMed ID: 27077309
[TBL] [Abstract][Full Text] [Related]
6. Synthesis of primaquine glyco-conjugates as potential tissue schizontocidal antimalarial agents.
Azad CS; Saxena M; Siddiqui AJ; Bhardwaj J; Puri SK; Dutta GP; Anand N; Saxena AK
Chem Biol Drug Des; 2017 Aug; 90(2):254-261. PubMed ID: 28102941
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of primaquine in patients with P. vivax malaria.
Bhatia SC; Saraph YS; Revankar SN; Doshi KJ; Bharucha ED; Desai ND; Vaidya AB; Subrahmanyam D; Gupta KC; Satoskar RS
Eur J Clin Pharmacol; 1986; 31(2):205-10. PubMed ID: 3542534
[TBL] [Abstract][Full Text] [Related]
8. A pilot randomized controlled trial to compare the effectiveness of two 14-day primaquine regimens for the radical cure of vivax malaria in South India.
Saravu K; Tellapragada C; Kulavalli S; Xavier W; Umakanth S; Brahmarouphu G; Srinivas NK; Channabasavaiah JP; Bava A; Saadi AV; Guddattu V; Satyamoorthy K; Bhat K
Malar J; 2018 Sep; 17(1):321. PubMed ID: 30176897
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic Assessment of Chloroquine-Primaquine Combined Regimen in Adult Cohort of Plasmodium vivax Malaria from Primary Care Centres in Southwestern India.
Saravu K; Kumar R; Ashok H; Kundapura P; Kamath V; Kamath A; Mukhopadhyay C
PLoS One; 2016; 11(6):e0157666. PubMed ID: 27315280
[TBL] [Abstract][Full Text] [Related]
10. [Drug resistance of Plasmodium falciparum and Plasmodium vivax strains in Cambodia (Cardamone Massif). Morphological characteristics of Plasmodium vivax].
Lapierre J; Coquelin B; Galal AA; Dupouy-Camet J; Faurant C; Tourte-Schaefer C; Ancelle T; Heyer F
Med Trop (Mars); 1984; 44(4):339-49. PubMed ID: 6394948
[TBL] [Abstract][Full Text] [Related]
11. Recurrent Plasmodium vivax malaria due to dose-dependent primaquine resistance: a case report.
Kristensen KL; Dragsted UB
Scand J Infect Dis; 2014 Jan; 46(1):63-5. PubMed ID: 23957539
[TBL] [Abstract][Full Text] [Related]
12. Association of Impaired Cytochrome P450 2D6 Activity Genotype and Phenotype With Therapeutic Efficacy of Primaquine Treatment for Latent Plasmodium vivax Malaria.
Baird JK; Louisa M; Noviyanti R; Ekawati L; Elyazar I; Subekti D; Chand K; Gayatri A; Instiaty ; Soebianto S; Crenna-Darusallam C; Djoko D; Hasto BD; Meriyenes D; Wesche D; Nelwan EJ; Sutanto I; Sudoyo H; Setiabudy R
JAMA Netw Open; 2018 Aug; 1(4):e181449. PubMed ID: 30646129
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of primaquine regimens for primaquine-resistant Plasmodium vivax malaria in Thailand.
Wilairatana P; Silachamroon U; Krudsood S; Singhasivanon P; Treeprasertsuk S; Bussaratid V; Phumratanaprapin W; Srivilirit S; Looareesuwan S
Am J Trop Med Hyg; 1999 Dec; 61(6):973-7. PubMed ID: 10674681
[TBL] [Abstract][Full Text] [Related]
14. Interaction with Modified Cyclodextrin as a Way to Increase the Antimalarial Activity of Primaquine.
Torres LH; de Carvalho LB; de Fátima Abreu Venceslau A; Jaime C; de Matos Alves Pinto L
Curr Drug Discov Technol; 2020; 17(5):670-681. PubMed ID: 31438828
[TBL] [Abstract][Full Text] [Related]
15. Scalable preparation and differential pharmacologic and toxicologic profiles of primaquine enantiomers.
Nanayakkara NP; Tekwani BL; Herath HM; Sahu R; Gettayacamin M; Tungtaeng A; van Gessel Y; Baresel P; Wickham KS; Bartlett MS; Fronczek FR; Melendez V; Ohrt C; Reichard GA; McChesney JD; Rochford R; Walker LA
Antimicrob Agents Chemother; 2014 Aug; 58(8):4737-44. PubMed ID: 24913163
[TBL] [Abstract][Full Text] [Related]
16. Design, characterization and antimalarial efficacy of PEGylated galactosylated nano lipid carriers of primaquine phosphate.
Baruah UK; Gowthamarajan K; Ravisankar V; Karri VVSR; Simhadri PK; Singh V; Babu PP
Artif Cells Nanomed Biotechnol; 2018 Dec; 46(8):1809-1829. PubMed ID: 29087218
[TBL] [Abstract][Full Text] [Related]
17. Quantifying and preventing Plasmodium vivax recurrences in primaquine-untreated pregnant women: An observational and modeling study in Brazil.
Corder RM; de Lima ACP; Khoury DS; Docken SS; Davenport MP; Ferreira MU
PLoS Negl Trop Dis; 2020 Jul; 14(7):e0008526. PubMed ID: 32735631
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic efficacy of chloroquine and chloroquine plus primaquine for the treatment of Plasmodium vivax in Ethiopia.
Yeshiwondim AK; Tekle AH; Dengela DO; Yohannes AM; Teklehaimanot A
Acta Trop; 2010 Feb; 113(2):105-13. PubMed ID: 19835832
[TBL] [Abstract][Full Text] [Related]
19. Safety, efficacy and pharmacokinetic evaluations of a new coated chloroquine tablet in a single-arm open-label non-comparative trial in Brazil: a step towards a user-friendly malaria vivax treatment.
Pereira D; Daher A; Zanini G; Maia I; Fonseca L; Pitta L; Ruffato R; Marchesini P; Fontes CJ
Malar J; 2016 Sep; 15():477. PubMed ID: 27639847
[TBL] [Abstract][Full Text] [Related]
20. A nanochitosan-D-galactose formulation increases the accumulation of primaquine in the liver.
Gomes F; Ribeiro AC; Sanches GS; Borges HS; Takahashi LAU; Daniel-Ribeiro CT; Tedesco AC; Nascimento JWL; Carvalho LJM
Antimicrob Agents Chemother; 2024 May; 68(5):e0091523. PubMed ID: 38517190
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
